title: Late chronic catechin antioxidant treatment is deleterious to the endothelial function in aging mice with established atherosclerosis.
abstract: Various antioxidants, including polyphenols, prevent the development of atherosclerosis in animal models, contrasting with the failure of antioxidants to provide benefits in patients with established atherosclerosis. We therefore tested in a mouse model the hypothesis that although catechin is atheroprotective in prevention, catechin brings no global vascular protection when initiated after established atherosclerosis, because aging associated with dyslipidemia has induced irreversible dysfunctions. To this end, LDLr(-/-); hApoB(+/+) atherosclerotic (ATX, 9 mo old) and pre-ATX (3 mo old) male mice were treated with catechin (30 mg x kg(-1) x day(-1)) up to 12 mo of age. Vascular function and endothelium/leukocyte interactions were studied at 12 mo old. The renal artery endothelium-dependent dilations were impaired with age whereas adhesion of leukocytes onto the native aortic endothelium was increased (P < 0.05). Aortic oxidative stress [reactive oxygen species (ROS)] increased (P < 0.05) at 3 mo in ATX and at 12 mo in wild-type mice. Aorta mRNA expression of NADPH oxidase increased, whereas that of manganese superoxide dismutase decreased in 12-mo-old ATX mice only. In mice with established ATX, catechin (from 9 to 12 mo) reduced (P < 0.05) by approximately 60% ROS without affecting plaque burden. Notably, catechin worsened endothelial dysfunction and further increased leukocyte adhesion (P < 0.05) in ATX mice. In contrast, the same catechin treatment reversed all age-related dysfunctions in wild-type mice. On the other hand, in pre-ATX mice treated for 9 mo with catechin, plaque burden was reduced by 64% (P < 0.05) and all vascular markers were normalized to the 3-mo-old values. These results demonstrate that an antioxidant treatment is deleterious in mice with established atherosclerosis.
authors.affiliation: Department of Physiology, Faculty of Medicine, Université de Montréal, Canada.
authors.forename: Marie-Eve
authors.initials: ME
authors.lastname: Gendron
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Théorêt
authors.forename: Aida M
authors.initials: AM
authors.lastname: Mamarbachi
authors.forename: Annick
authors.initials: A
authors.lastname: Drouin
authors.forename: Albert
authors.initials: A
authors.lastname: Nguyen
authors.forename: Virginie
authors.initials: V
authors.lastname: Bolduc
authors.forename: Nathalie
authors.initials: N
authors.lastname: Thorin-Trescases
authors.forename: Yahye
authors.initials: Y
authors.lastname: Merhi
authors.forename: Eric
authors.initials: E
authors.lastname: Thorin
mesh_terms: D000375:Aging / Q000502:physiology*; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001055:Apolipoproteins B / Q000235:genetics / Q000502:physiology; D050197:Atherosclerosis / Q000378:metabolism / Q000503:physiopathology*; D002392:Catechin / Q000494:pharmacology*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology*; D008055:Lipids / Q000097:blood; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D018384:Oxidative Stress / Q000502:physiology; D017382:Reactive Oxygen Species / Q000378:metabolism; D011973:Receptors, LDL / Q000235:genetics / Q000502:physiology; D013481:Superoxides / Q000378:metabolism
chemical_list: D000975:Antioxidants; D001055:Apolipoproteins B; D008055:Lipids; D017382:Reactive Oxygen Species; D011973:Receptors, LDL; D013481:Superoxides; D002392:Catechin
references.citation: Int J Mol Med. 2005 Oct;16(4):533-40
references.pmid: 16142383
references.citation: Biochem Pharmacol. 1988 Mar 1;37(5):837-41
references.pmid: 2830882
references.citation: Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4544-9
references.pmid: 9539774
references.citation: Atherosclerosis. 1997 Nov;135(1):37-47
references.pmid: 9395271
references.citation: Pflugers Arch. 2010 May;459(6):1015-23
references.pmid: 20107832
references.citation: Drugs Exp Clin Res. 2002;28(2-3):49-62
references.pmid: 12224378
references.citation: Cardiovasc Res. 2005 Oct 1;68(1):26-36
references.pmid: 16009356
references.citation: Biochem J. 2007 May 15;404(1):1-13
references.pmid: 17447894
references.citation: FEBS Lett. 1998 Aug 14;433(1-2):44-6
references.pmid: 9738930
references.citation: Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2508-15
references.pmid: 17644574
references.citation: Nature. 2003 Sep 11;425(6954):191-6
references.pmid: 12939617
references.citation: Circulation. 2010 Feb 16;121(6):750-8
references.pmid: 20124123
references.citation: Science. 2004 Mar 26;303(5666):2011-5
references.pmid: 14976264
references.citation: Circulation. 2002 Apr 30;105(17):2107-11
references.pmid: 11980692
references.citation: Int J Biochem Cell Biol. 2007;39(1):44-84
references.pmid: 16978905
references.citation: Nat Rev Drug Discov. 2006 Jun;5(6):493-506
references.pmid: 16732220
references.citation: N Engl J Med. 2000 Jul 6;343(1):16-22
references.pmid: 10882764
references.citation: Am J Clin Nutr. 2005 Jan;81(1 Suppl):317S-325S
references.pmid: 15640497
references.citation: Eur J Pharmacol. 2004 Oct 1;500(1-3):299-313
references.pmid: 15464042
references.citation: Circulation. 2008 Jan 22;117(3):421-8
references.pmid: 18158360
references.citation: Pharmacol Ther. 2009 May;122(2):140-9
references.pmid: 19285526
references.citation: Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2744-52
references.pmid: 9409251
references.citation: Am J Cardiol. 2008 May 22;101(10A):75D-86D
references.pmid: 18474278
references.citation: Mech Ageing Dev. 2008 May;129(5):261-70
references.pmid: 18302967
references.citation: Arterioscler Thromb Vasc Biol. 1998 Sep;18(9):1506-13
references.pmid: 9743241
references.citation: Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H451-8
references.pmid: 16980343
references.citation: Circ Res. 2009 Mar 27;104(6):e42-54
references.pmid: 19265038
references.citation: Am J Clin Nutr. 2001 Oct;74(4):418-25
references.pmid: 11566638
references.citation: Proc Soc Exp Biol Med. 1998 Sep;218(4):376-81
references.pmid: 9714083
references.citation: J Biol Chem. 2005 Apr 29;280(17):17038-45
references.pmid: 15684413
references.citation: Nature. 2006 Nov 16;444(7117):337-42
references.pmid: 17086191
references.citation: Trends Biochem Sci. 2007 Dec;32(12):555-60
references.pmid: 17980602
references.citation: Physiol Res. 2000;49(1):11-8
references.pmid: 10805400
references.citation: Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1367-73
references.pmid: 15166009
references.citation: Mech Ageing Dev. 2007 Nov-Dec;128(11-12):662-71
references.pmid: 18022214
references.citation: Am J Cardiol. 2008 May 22;101(10A):14D-19D
references.pmid: 18474268
references.citation: Nature. 2004 Aug 5;430(7000):686-9
references.pmid: 15254550
references.citation: Transplantation. 2007 Dec 15;84(11):1474-82
references.pmid: 18091524
references.citation: Diabetes. 2006 Aug;55(8):2180-91
references.pmid: 16873680
references.citation: Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H689-97
references.pmid: 19112095
references.citation: Can J Physiol Pharmacol. 2008 Nov;86(11):761-9
references.pmid: 19011671
references.citation: Br J Pharmacol. 2009 Jun;157(4):527-36
references.pmid: 19630832
references.citation: Circulation. 2009 Mar 17;119(10):1433-41
references.pmid: 19289648
references.citation: J Nutr. 2001 Jan;131(1):27-32
references.pmid: 11208934
references.citation: Hypertension. 1992 Feb;19(2):117-30
references.pmid: 1737645